Article
DOCK6 promotes chemo- and radioresistance of gastric cancer by modulating WNT/β-catenin signaling and cancer stem cell traits.
Oncogene - 1 Sept 2020
Chi Hsiang-Cheng, Tsai Chung-Ying, Wang Chia-Siu, Yang Huang-Yu, Lo Chien-Hui, Wang Won-Jing, Lee Kam-Fai, Lai Li-Yin, Hong Ji-Hong, Chang Yen-Fang, Tsai Ming-Ming, Yeh Chau-Ting, Wu Cheng Heng, Hsieh Ching-Chuan, Wang Lu-Hai, Chen Wei-Jan, Lin Kwang-Huei
Abstract excerpt
Gastric cancer (GC) is the third leading cause of cancer-related mortality worldwide and prognosis after potentially curative gastrectomy remains poor. Administration of GC-targeting molecules in combination with adjuvant chemo- or radiotherapy following surgical resection has been proposed as a potentially effective treatment option. Here, we have identified DOCK6, a guanine nucleotide exchange factor (GEF) for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
